Sutton Wealth Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-340
Closed -$15.6K 1221
2022
Q4
$15.6K Buy
340
+1
+0.3% +$47 0.01% 793
2022
Q3
$17.2K Hold
339
0.01% 708
2022
Q2
$15.4K Hold
339
0.01% 754
2022
Q1
$15.8K Sell
339
-2
-0.6% -$89 0.01% 798
2021
Q4
$17.1K Buy
341
+5
+1% +$259 0.01% 758
2021
Q3
$17.8K Hold
336
0.01% 731
2021
Q2
$20.5K Hold
336
0.01% 693
2021
Q1
$16.4K Hold
336
0.01% 730
2020
Q4
$13.6K Hold
336
0.01% 720
2020
Q3
$10.9K Hold
336
0.01% 711
2020
Q2
$8.87K Hold
336
﹤0.01% 738
2020
Q1
$8.37K Hold
336
0.01% 703
2019
Q4
$12.1K Hold
336
0.01% 764
2019
Q3
$11.5K Hold
336
0.01% 757
2019
Q2
$9.4K Hold
336
0.01% 782
2019
Q1
$10.4K Buy
+336
New +$8.97K 0.01% 773
2018
Q4
Sell
-246
Closed -$9.53K 1165
2018
Q3
$9.53K Hold
246
0.01% 793
2018
Q2
$8.24K Hold
246
0.01% 867
2018
Q1
$8.91K Hold
246
0.01% 841
2017
Q4
$7.83K Buy
+246
New +$8.43K 0.01% 833

Other funds holding LMAT

Sutton Wealth Advisors's LMAT Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of LeMaitre Vascular (LMAT) in Q1 2023, closing a stake of 340 shares — an estimated $15.6K sold.

Sutton Wealth Advisors first reported a position in LMAT in Q4 2017 and held it in 20 quarters. The position peaked at $20.5K in Q2 2021. 184 funds tracked by Wall St. Rank hold LMAT as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining LeMaitre Vascular position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 340 LeMaitre Vascular shares in Q1 2023, an estimated $15.6K.
  • Sutton Wealth Advisors first reported a position in LeMaitre Vascular in Q4 2017 and held it in 20 quarters.
  • Sutton Wealth Advisors's LeMaitre Vascular position peaked at $20.5K in Q2 2021.
  • 184 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.